Dr. Schwartz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1875 Dempster St
Ste 550
Park Ridge, IL 60068Phone+1 847-384-1420Fax+1 847-318-9332
Education & Training
Brigham and Women's HospitalFellowship, Vascular Surgery, 1994 - 1995
Duke University HospitalResidency, Surgery, 1987 - 1994
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1987
Certifications & Licensure
IL State Medical License 1995 - 2026
NC State Medical License 1989 - 2025
CA State Medical License 2013 - 2024
WI State Medical License 2013 - 2017
MI State Medical License 2000 - 2016- American Board of Surgery Surgery
- American Board of Surgery Vascular Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 185 citationsRandomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease.Marc Bosiers, Dierk Scheinert, Patrick Peeters, Giovanni Torsello, Thomas Zeller
Journal of Vascular Surgery. 2012-02-01 - 28 citationsBioresorbable Everolimus-Eluting Vascular Scaffold for Patients With Peripheral Artery Disease (ESPRIT I): 2-Year Clinical and Imaging ResultsJohannes Lammer, Marc Bosiers, Koen Deloose, Andrej Schmidt, Thomas Zeller
JACC. Cardiovascular Interventions. 2016-06-13 - 112 citationsFirst clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive diseaseJohannes Lammer, Marc Bosiers, Thomas Zeller, Martin Schillinger, Els Boone
Journal of Vascular Surgery. 2011-08-01
Press Mentions
Efemoral Medical Announces Series A1 FundingDecember 13th, 2022- Efemoral Medical Awarded Phase II SBIR Grant from NIH to Advance Treatment for Peripheral Artery DiseaseSeptember 22nd, 2022
- AI Measures Fat Around the Heart, a Key to Predicting Heart AttacksFebruary 15th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
